Enfusion . Quarterly Income Statements Chart
Quarterly
|
Annual
Enfusion . Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues: | ||||||||||||||
| platform subscriptions | 49,252,000 | 47,786,000 | 45,794,000 | 44,689,000 | 43,054,000 | 40,857,000 | 39,610,000 | 37,998,000 | 37,804,000 | 35,953,000 | 33,560,000 | 31,551,000 | 28,936,000 | 27,136,000 |
| managed services | 3,211,000 | 3,078,000 | 3,223,000 | 3,177,000 | 3,056,000 | 3,028,000 | 2,945,000 | 2,744,000 | 2,691,000 | 2,504,000 | 2,396,000 | 2,230,000 | 1,935,000 | 1,890,000 |
| other | 475,000 | 302,000 | 438,000 | 186,000 | 376,000 | 472,000 | 166,000 | 229,000 | 22,000 | 694,000 | 584,000 | 360,000 | 982,000 | 19,000 |
| total revenues | 52,938,000 | 51,166,000 | 49,455,000 | 48,052,000 | 46,486,000 | 44,357,000 | 42,721,000 | 40,971,000 | 40,517,000 | 39,151,000 | 36,540,000 | 34,141,000 | ||
| yoy | 13.88% | 15.35% | 15.76% | 17.28% | 14.73% | 13.30% | 16.92% | 20.01% | ||||||
| qoq | 3.46% | 3.46% | 2.92% | 3.37% | 4.80% | 3.83% | 4.27% | 1.12% | 3.49% | 7.15% | 7.03% | |||
| | ||||||||||||||
| cost of revenues: | ||||||||||||||
| total cost of revenues | 16,398,000 | 16,340,000 | 15,962,000 | 16,174,000 | 15,624,000 | 14,507,000 | 14,208,000 | 13,302,000 | 13,296,000 | 11,974,000 | 10,847,000 | 10,983,000 | 10,164,000 | 8,095,000 |
| gross profit | 36,540,000 | 34,826,000 | 33,493,000 | 31,878,000 | 30,862,000 | 29,850,000 | 28,513,000 | 27,669,000 | 27,221,000 | 27,177,000 | 25,693,000 | 23,158,000 | 21,689,000 | 20,950,000 |
| yoy | 18.40% | 16.67% | 17.47% | 15.21% | 13.38% | 9.84% | 10.98% | 19.48% | 25.51% | 29.72% | ||||
| qoq | 4.92% | 3.98% | 5.07% | 3.29% | 3.39% | 4.69% | 3.05% | 1.65% | 0.16% | 5.78% | 10.95% | 6.77% | 3.53% | |
| gross margin % | 69.02% | 68.06% | 67.72% | 66.34% | 66.39% | 67.29% | 66.74% | 67.53% | 67.18% | 69.42% | 70.31% | 67.83% | ||
| operating expenses: | ||||||||||||||
| general and administrative | 21,148,000 | 18,782,000 | 18,673,000 | 20,223,000 | 17,115,000 | 16,721,000 | 16,326,000 | 14,473,000 | 15,073,000 | 13,094,000 | 18,302,000 | 22,295,000 | 128,229,000 | 8,546,000 |
| sales and marketing | 6,570,000 | 6,221,000 | 6,021,000 | 6,217,000 | 5,552,000 | 5,503,000 | 5,277,000 | 4,086,000 | 6,001,000 | 7,278,000 | 7,575,000 | 8,432,000 | 39,402,000 | 4,901,000 |
| technology and development | 7,238,000 | 6,842,000 | 6,096,000 | 6,551,000 | 6,061,000 | 4,937,000 | 4,464,000 | 4,431,000 | 4,775,000 | 3,864,000 | 3,722,000 | 4,802,000 | 146,556,000 | 2,600,000 |
| total operating expenses | 34,956,000 | 31,845,000 | 30,790,000 | 32,991,000 | 28,728,000 | 27,161,000 | 26,067,000 | 22,990,000 | 25,849,000 | 24,236,000 | 29,599,000 | 35,529,000 | 314,187,000 | 16,047,000 |
| income from operations | 1,584,000 | 2,981,000 | 2,703,000 | -1,113,000 | 2,134,000 | 2,689,000 | 2,446,000 | 4,679,000 | 1,372,000 | 2,941,000 | -3,906,000 | -12,371,000 | -292,498,000 | 4,903,000 |
| yoy | -25.77% | 10.86% | 10.51% | -123.79% | 55.54% | -8.57% | -162.62% | -137.82% | -100.47% | -40.02% | ||||
| qoq | -46.86% | 10.28% | -342.86% | -152.16% | -20.64% | 9.93% | -47.72% | 241.03% | -53.35% | -175.29% | -68.43% | -95.77% | -6065.69% | |
| operating margin % | 2.99% | 5.83% | 5.47% | -2.32% | 4.59% | 6.06% | 5.73% | 11.42% | 3.39% | 7.51% | -10.69% | -36.24% | ||
| non-operating income: | ||||||||||||||
| payment to related party | -1,501,000 | |||||||||||||
| loss on extinguishment of debt | -19,500 | -78,000 | ||||||||||||
| interest income | 533,000 | 487,000 | 356,000 | 317,000 | ||||||||||
| other income | 341,000 | -607,000 | -111,000 | -82,000 | -1,673,000 | 417,000 | 241,000 | 411,000 | -590,000 | -52,000 | 1,000 | 3,000 | -1,214,000 | 29,000 |
| total non-operating income | 874,000 | -120,000 | 245,000 | 235,000 | 46,000 | 339,000 | -1,260,000 | 411,000 | -3,000 | -1,521,000 | -1,456,000 | |||
| income before income taxes | 2,458,000 | 2,861,000 | 2,948,000 | -878,000 | 2,180,000 | 3,028,000 | 1,186,000 | 5,090,000 | 1,206,000 | 2,885,000 | -3,906,000 | -12,374,000 | -294,019,000 | 3,447,000 |
| income taxes | 2,286,000 | 904,000 | 401,000 | -117,000 | 1,280,000 | 367,000 | 188,000 | 396,000 | 418,000 | 287,000 | 219,000 | 150,000 | 176,000 | 154,000 |
| net income | 172,000 | 1,957,000 | 2,547,000 | -761,000 | 900,000 | 2,661,000 | 998,000 | 4,694,000 | 788,000 | 2,598,000 | -4,125,000 | -12,524,000 | -293,894,000 | 3,293,000 |
| yoy | -80.89% | -26.46% | 155.21% | -116.21% | 14.21% | 2.42% | -124.19% | -137.48% | -100.27% | -21.11% | ||||
| qoq | -91.21% | -23.16% | -434.69% | -184.56% | -66.18% | 166.63% | -78.74% | 495.69% | -69.67% | -162.98% | -67.06% | -95.74% | -9024.81% | |
| net income margin % | 0.32% | 3.82% | 5.15% | -1.58% | 1.94% | 6.00% | 2.34% | 11.46% | 1.94% | 6.64% | -11.29% | -36.68% | ||
| net income attributable to non-controlling interests | 51,000 | 542,000 | 721,000 | -222,000 | 277,000 | 833,000 | 369,000 | 1,749,000 | 294,000 | 1,059,000 | -1,703,000 | -5,259,000 | ||
| net income attributable to enfusion, inc. | 121,000 | 1,415,000 | 1,826,000 | -539,000 | 623,000 | 1,828,000 | 629,000 | 2,945,000 | 494,000 | 1,539,000 | -2,422,000 | -7,265,000 | ||
| net income per class a common shares attributable to enfusion, inc.: | ||||||||||||||
| basic | 20 | 20 | -10 | 10 | 20 | 10 | 40 | -27.5 | 20 | |||||
| diluted | 20 | 20 | -10 | 10 | 20 | 10 | 40 | -27.5 | 20 | |||||
| weighted-average number of class a common shares outstanding: | ||||||||||||||
| basic | 92,045,000 | 92,904,000 | 91,480,000 | 89,509,000 | 88,202,000 | 87,739,000 | 88,314,000 | 88,863,000 | 85,156,000 | |||||
| diluted | 129,550,000 | 128,984,000 | 128,852,000 | 89,509,000 | 129,429,000 | 127,841,000 | 129,856,000 | 132,346,000 | 131,760,000 | |||||
| interest expense | -2,750 | -4,000 | -1,000 | -6,000 | -307,000 | -1,485,000 | ||||||||
| total non-operating expense | -166,000 | -56,000 | ||||||||||||
| net income per class a common shares attributable to enfusion, inc.: | ||||||||||||||
| basic and diluted | -30 | -100 | ||||||||||||
| weighted-average number of class a common shares outstanding: | ||||||||||||||
| basic and diluted | 85,393,000 | 84,581,000 | 83,384,000 | 83,045,000 | ||||||||||
| total net revenues | 19,961,750 | 29,045,000 |
We provide you with 20 years income statements for Enfusion . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Enfusion . stock. Explore the full financial landscape of Enfusion . stock with our expertly curated income statements.
The information provided in this report about Enfusion . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.